Furthermore, variations in the expression of MDA5 and OAS2 have been observed in children and adolescents with LC, compared with recovered patients without LC symptoms (matched controls, MC) and healthy controls. The gene discussed is IFIH1; the disease is laryngotracheoesophageal cleft.